TxFlow Level Up: trade perps and earn up to 300 USDC at $4M volume. Until Nov 2 Join
Settings8H · net · $10k
LanguageThe language of the site
ThemeDark, or a soft blue-grey
FundingPeriod funding rates are shown in
UnitsPercent or basis points
CostsCount taker fees and slippage in Net
SizePosition per leg used for Net and slippage
ExchangesWhich exchanges to include everywhere
My profile →
My profile
Backtest 30d
LegExchangePriceFund. /8hEach paymentNext inOIVol 24hLev
LONG185.88+0.0100pay 0.0013% / 1h50m 32s$14K$115K20xLong TxFlow5% off
SHORT185.41+0.0050get 0.0006% / 1h50m 32s$7K$291K5xShort Ondo Perps5% off
Price gap−0.253%
Funding gap−0.0050% /8h

Both sides work against this direction now: funding costs $1 a day on $10k and the gap is 0.207% under its 7d average. Swap the legs.

If you open now and hold

on $10k a leg · figures of the last 7D, not a forecast
Funding−$20−0.0050% /8h now · paid −0.198% over the last 7D
Price−$21spread −0.253% now, avg −0.045% → −0.207% if it goes back
Costs−$900.898% of $10k · taker + slippage, in and out
Result−$130−1.30%+ Points / potential airdropTxFlow: points · Ondo Perps: points · farm boardWhat the last 7D really paid, hour by hour → backtest

Price and funding

1h · history
ENTRY / EXIT · 7D
Entry now—
Entry average—
Best entry—
Exit now—
Exit average—
Best exit—
Exit free—
PRICE SPREAD · 7D
Now−0.253%
Average—
Range—
Wider than now—
FUNDING SPREAD · 7D
Average /8h—
Highest—
Lowest—
Paid you—

Where the spread has been, last 7D

share of time at each level

Funding on every exchange

/8h

MRNA on 27 exchanges

lowest funding first

Before you open

3 ok · 3 to watch
  • Watch: Thin at this size36.3 / 8.6 bp
    At $10k entering TxFlow costs 36.3 bp, fee and slippage, 4.2× Ondo Perps’s.
  • Note: Margin at max leverage$500 + $2,000
    TxFlow 20x, Ondo Perps 5x. Keep about 2× this so a sharp move doesn’t liquidate one leg.
  • OK: Same payment interval1h / 1h
    Both legs pay at the same time.
    Next 24h at the current rates, on $10k a leg: −$1.49Long TxFlow: 24 payments, −$3.00; short Ondo Perps: 24 payments, +$1.51.
  • Watch: Gap narrower than usual−0.253% vs −0.045%
    Less room for the price leg to pay you. If it goes back to average, the short loses.
  • Watch: Short leg is thinner$7K vs $14K OI
    Ondo Perps sets your exit cost. Check its book before closing.
  • OK: Points on a legTxFlow points · Ondo Perps points
    Volume here counts toward the points program.
  • OK: No KYC on either legTxFlow No · Ondo Perps No
    Both exchanges let you trade without ID.

Profit calculator

both legs, in and out
Position, each leg
Hold for
Orders
Price spread
Funding rate
Funding earned−0.0094%/8h × 21 periods−$19.78
Price spread−0.253% → −0.045% (7d avg)−$20.74
Slippage, 4 orderslive order books−$75.77
Fee TxFlow bp × 2 orders−$9.00
Fee Ondo Perps bp × 2 orders−$5.00
Net · 7 days · $10k−$130.29
Costs to cover0.898%Break-evennever at this rate
Slippage: TxFlow: live order book, 42 min ago; Ondo Perps: live order book, 61 min ago

Cost to enter

taker + slippage from mid, one side
BUY · LONGTxFlow4.6336.3 bp−$3699.9 bp−$999doesn’t fitdoesn’t fit
SELL · SHORTOndo Perps5.458.6 bp−$930.2 bp−$302doesn’t fitdoesn’t fit

Closing costs about the same again.

Alert

MRNA news

posts that mention MRNA, from every exchangeSearch all news →
10-25 09:09AZverseListingnew market mrna_usdt ($MRNA) seen by our collector
10-22 20:48ArcusOther$MRNA fell 25% today and was halted intraday on its primary exchange. The MRNA perp on Arcus kept trading through the halt. Traders could open, reduce, or close positions the entire time - as there is no halt state on Arcus perps. Markets run 24/7. Read more about Arcus RWA Perps here: @arcus_xyz on X ↗
10-22 19:35PhoenixOtherModerna falls after reported leak of Phase 3 melanoma vaccine data showing a 42% cut in recurrence risk, below Phase 2's 49%. $MRNA is trading at $195 on Phoenix, 24/7. @PhoenixTrade on X ↗
10-22 19:27BitgetOtherStay on top of fast-moving stock markets with Bitget Stock Perps. 📈📉 Here's the latest on Moderna $MRNA today ⤵️ @bitget on X ↗
10-20 17:07PhoenixOtherJUST IN: Moderna $MRNA is still climbing, up nearly 7% in the last 24 hours ahead of Saturday's Phase 3 cancer vaccine data at ESMO. @PhoenixTrade on X ↗
10-19 13:46PhoenixOtherJUST IN: $MRNA jumps 8.45% in anticipation of their Stage 3 cancer vaccine clinical trial results releasing on October 24. @PhoenixTrade on X ↗